297 related articles for article (PubMed ID: 36285145)
21. Tissue engineering vascular grafts a fortiori: looking back and going forward.
G N; Tan A; Gundogan B; Farhatnia Y; Nayyer L; Mahdibeiraghdar S; Rajadas J; De Coppi P; Davies AH; Seifalian AM
Expert Opin Biol Ther; 2015 Feb; 15(2):231-44. PubMed ID: 25427995
[TBL] [Abstract][Full Text] [Related]
22. Improvement of a Novel Small-diameter Tissue-engineered Arterial Graft With Heparin Conjugation.
Matsuzaki Y; Miyamoto S; Miyachi H; Iwaki R; Shoji T; Blum K; Chang YC; Kelly J; Reinhardt JW; Nakayama H; Breuer CK; Shinoka T
Ann Thorac Surg; 2021 Apr; 111(4):1234-1241. PubMed ID: 32946845
[TBL] [Abstract][Full Text] [Related]
23. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery.
Cho SW; Kim IK; Kang JM; Song KW; Kim HS; Park CH; Yoo KJ; Kim BS
Tissue Eng Part A; 2009 Apr; 15(4):901-12. PubMed ID: 18783324
[TBL] [Abstract][Full Text] [Related]
24. Small-Caliber Tissue-Engineered Vascular Grafts Based on Human-Induced Pluripotent Stem Cells: Progress and Challenges.
Ji J; Xu H; Li C; Luo J
Tissue Eng Part B Rev; 2023 Aug; 29(4):441-455. PubMed ID: 36884294
[TBL] [Abstract][Full Text] [Related]
25. Cellularized small-caliber tissue-engineered vascular grafts: looking for the ultimate gold standard.
Fayon A; Menu P; El Omar R
NPJ Regen Med; 2021 Aug; 6(1):46. PubMed ID: 34385472
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts.
Ruiz-Rosado JD; Lee YU; Mahler N; Yi T; Robledo-Avila F; Martinez-Saucedo D; Lee AY; Shoji T; Heuer E; Yates AR; Pober JS; Shinoka T; Partida-Sanchez S; Breuer CK
FASEB J; 2018 Jun; 32(12):fj201800458. PubMed ID: 29906242
[TBL] [Abstract][Full Text] [Related]
27. Systematic Review of Tissue-Engineered Vascular Grafts.
Durán-Rey D; Crisóstomo V; Sánchez-Margallo JA; Sánchez-Margallo FM
Front Bioeng Biotechnol; 2021; 9():771400. PubMed ID: 34805124
[TBL] [Abstract][Full Text] [Related]
28. Functionality, growth and accelerated aging of tissue engineered living autologous vascular grafts.
Kelm JM; Emmert MY; Zürcher A; Schmidt D; Begus Nahrmann Y; Rudolph KL; Weber B; Brokopp CE; Frauenfelder T; Leschka S; Odermatt B; Jenni R; Falk V; Zünd G; Hoerstrup SP
Biomaterials; 2012 Nov; 33(33):8277-85. PubMed ID: 22906604
[TBL] [Abstract][Full Text] [Related]
29. Electrospun scaffolds for tissue engineering of vascular grafts.
Hasan A; Memic A; Annabi N; Hossain M; Paul A; Dokmeci MR; Dehghani F; Khademhosseini A
Acta Biomater; 2014 Jan; 10(1):11-25. PubMed ID: 23973391
[TBL] [Abstract][Full Text] [Related]
30. Comparison of a closed system to a standard open technique for preparing tissue-engineered vascular grafts.
Kurobe H; Maxfield MW; Naito Y; Cleary M; Stacy MR; Solomon D; Rocco KA; Tara S; Lee AY; Sinusas AJ; Snyder EL; Shinoka T; Breuer CK
Tissue Eng Part C Methods; 2015 Jan; 21(1):88-93. PubMed ID: 24866863
[TBL] [Abstract][Full Text] [Related]
31. Computational Characterization of Mechanical, Hemodynamic, and Surface Interaction Conditions: Role of Protein Adsorption on the Regenerative Response of TEVGs.
Riveros A; Garcia-Brand AJ; Rodriguez-Soto MA; Sandoval N; Muñoz-Camargo C; Cruz JC; Briceño JC
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163056
[TBL] [Abstract][Full Text] [Related]
32. The Tissue-Engineered Vascular Graft-Past, Present, and Future.
Pashneh-Tala S; MacNeil S; Claeyssens F
Tissue Eng Part B Rev; 2016 Feb; 22(1):68-100. PubMed ID: 26447530
[TBL] [Abstract][Full Text] [Related]
33. Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells.
Generali M; Casanova EA; Kehl D; Wanner D; Hoerstrup SP; Cinelli P; Weber B
Acta Biomater; 2019 Oct; 97():333-343. PubMed ID: 31344511
[TBL] [Abstract][Full Text] [Related]
34. A novel strategy to engineer small-diameter vascular grafts from marrow-derived mesenchymal stem cells.
Zhao J; Liu L; Wei J; Ma D; Geng W; Yan X; Zhu J; Du H; Liu Y; Li L; Chen F
Artif Organs; 2012 Jan; 36(1):93-101. PubMed ID: 21790675
[TBL] [Abstract][Full Text] [Related]
35. Effects of weaving parameters on the properties of completely biological tissue-engineered vascular grafts.
Roudier G; Hourques M; Da Silva N; Gluais M; Binyet E; Olive JM; L'Heureux N
Biofabrication; 2023 Nov; ():. PubMed ID: 37972404
[TBL] [Abstract][Full Text] [Related]
36. Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease.
Dean EW; Udelsman B; Breuer CK
Yale J Biol Med; 2012 Jun; 85(2):229-38. PubMed ID: 22737051
[TBL] [Abstract][Full Text] [Related]
37. Small Diameter Cell-Free Tissue-Engineered Vascular Grafts: Biomaterials and Manufacture Techniques to Reach Suitable Mechanical Properties.
Rodríguez-Soto MA; Polanía-Sandoval CA; Aragón-Rivera AM; Buitrago D; Ayala-Velásquez M; Velandia-Sánchez A; Peralta Peluffo G; Cruz JC; Muñoz Camargo C; Camacho-Mackenzie J; Barrera-Carvajal JG; Briceño JC
Polymers (Basel); 2022 Aug; 14(17):. PubMed ID: 36080517
[TBL] [Abstract][Full Text] [Related]
38. Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts.
Carrabba M; Madeddu P
Front Bioeng Biotechnol; 2018; 6():41. PubMed ID: 29721495
[TBL] [Abstract][Full Text] [Related]
39. Biofabrication of small diameter tissue-engineered vascular grafts.
Weekes A; Bartnikowski N; Pinto N; Jenkins J; Meinert C; Klein TJ
Acta Biomater; 2022 Jan; 138():92-111. PubMed ID: 34781026
[TBL] [Abstract][Full Text] [Related]
40. Strategies in cell-free tissue-engineered vascular grafts.
Yuan H; Chen C; Liu Y; Lu T; Wu Z
J Biomed Mater Res A; 2020 Mar; 108(3):426-445. PubMed ID: 31657523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
